BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 321160)

  • 1. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
    Peers J; McDonald BL; Dawkins RL
    Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
    Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
    Cojocaru IM; Cojocaru M; Muşuroi C
    Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
    Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
    J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis-associated antibodies in asymptomatic thymoma.
    Moore HJ; Woods EL
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):308-10. PubMed ID: 3968916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striational autoantibodies: quantitative detection by enzyme immunoassay in myasthenia gravis, thymoma, and recipients of D-penicillamine or allogeneic bone marrow.
    Cikes N; Momoi MY; Williams CL; Howard FM; Hoagland HC; Whittingham S; Lennon VA
    Mayo Clin Proc; 1988 May; 63(5):474-81. PubMed ID: 3283472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzyme-linked immunosorbent assay for antistriational antibodies associated with myasthenia gravis and thymoma: comparison with indirect immunofluorescence.
    Carrano JA; Swanson NR; Dawkins RL
    J Immunol Methods; 1983 May; 59(3):301-14. PubMed ID: 6343491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum anti-titin antibody in patients with myasthenia gravis].
    Li YF; Zhang JB; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis: difference between thymoma-associated antibodies and cross-striational skeletal muscle antibodies.
    Gilhus NE; Aarli JA; Matre R
    Neurology; 1984 Feb; 34(2):246-9. PubMed ID: 6363971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunofluorescence studies in myasthenia].
    Slomkowska H
    Neurol Neurochir Pol; 1972; 6(2):205-10. PubMed ID: 4555306
    [No Abstract]   [Full Text] [Related]  

  • 19. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
    Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
    J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.